Table of Content

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. United States Diabetes Market


6. United States Diabetes Population & Forecast

6.1 Type 1 Diabetes
6.2 Type 2 Diabetes


7. Market Share – United States Diabetes Analysis

7.1 By Types


8. Continuous Glucose Monitoring Market (CGM) – Market & Users

8.1 CGM Market by Components

8.1.1 Glucose Sensor Market
8.1.2 CGM Transmitter Market

8.2 CGM User
8.3 Reimbursement Policies of CGM Devices in United States


9. Blood Glucose Device (SMBG) – United States Market & Users

9.1 Market

9.1.1 Type 1 (SMBG)
9.1.2 Type 2 (SMBG)

9.2 Test Strips Market

9.2.1 Type 1
9.2.2 Type 2

9.3 Lancet Market and Forecast

9.3.1 Type 1
9.3.2 Type 2

9.4 Meter Market and Forecast

9.4.1 Type 1
9.4.2 Type 2

9.5 Blood Glucose (SMBG) Users

9.5.1 Type 1
9.5.2 Type 2

9.6 Reimbursement Policies of Blood Glucose Devices in United States


10. Insulin Pen – United States Market & User

10.1 Insulin Pen Market

10.1.1 Disposable Insulin Pen
10.1.2 Reusable Insulin Pen
10.1.3 Smart Insulin Pen

10.2 Insulin Pen User

10.2.1 Disposable Insulin Pen
10.2.2 Reusable Insulin Pen
10.2.3 Smart Insulin Pen

10.3 Insulin Pen Needle Market

10.4 Reimbursement Policies of Insulin Pen in United States


11. Insulin Pump - United States Market & Users

11.1 Insulin Pump Market

11.1.1 Type 1
11.1.2 Type 2

11.2 Insulin Pump User

11.2.1 Type 1
11.2.2 Type 2

11.3 Differentiation Points of Insulin Pump Products in United States

11.3.1 Animas Vibe
11.3.2 Medtronic 530G with Enlite
11.3.3 Insulet OmniPod
11.3.4 Tandem t: slim
11.3.5 Roche Accu-Chek Combo

11.4 Training Model for Patients & HCP – of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care

11.4.1 Medtronic

11.5 Insulet Corporation

11.5.1 Training Structure for New Patients - Insulet Corporation

11.6 Animas Corporation

11.6.1 Training Modules for New Patients
11.6.2 Training Modules for HCP (Health Care Professional)

11.7 Tandem Diabetes Care

11.8 Reimbursement Policies on Insulin Pump


12. Insulin Pen – Company Analysis

12.1 B. Braun Melsungen AG

12.1.1 Overview
12.1.2 Recent Development
12.1.3 Revenue

12.2 Eli Lilly

12.2.1 Overview
12.2.2 Recent Development
12.2.3 Revenue

12.3 Terumo Corporation

12.3.1 Overview
12.3.2 Recent Development
12.3.3 Revenue

12.4 BD

12.4.1 Overview
12.4.2 Recent Development
12.4.3 Revenue

12.5 Novo Nordisk A/S

12.5.1 Overview
12.5.2 Recent Development
12.5.3 Revenue

12.6 Ypsomed AG

12.6.1 Overview
12.6.2 Recent Development
12.6.3 Revenue


13. Insulin Pump – Company Analysis

13.1 Medtronic

13.1.1 Overview
13.1.2 Recent Development
13.1.3 Revenue

13.2 Insulet Corporation

13.2.1 Overview
13.2.2 Recent Development
13.2.3 Revenue


14. SMBG – Company Analysis

14.1 DarioHealth Corp

14.1.1 Overview
14.1.2 Recent Development
14.1.3 Revenue

14.2 Abbott Laboratories

14.2.1 Overview
14.2.2 Recent Development
14.2.3 Revenue


15. CGM – Company Analysis

15.1 Dexcom Inc

15.1.1 Overview
15.1.2 Recent Development
15.1.3 Revenue

15.2 Roche

15.2.1 Overview
15.2.2 Recent Development
15.2.3 Revenue

15.3 Tandem Diabetes Care

15.3.1 Overview
15.3.2 Recent Development
15.3.3 Revenue



List of Figures

Figure-01: United States – Diabetes Market (Billion US$), 2017 – 2022
Figure-02: United States – Forecast for Diabetes Market (Billion US$), 2023 – 2028
Figure-03: United States – Type 1 Diabetes Population (Thousand), 2017 – 2022
Figure-04: United States – Forecast for Type 1 Diabetes Population (Thousand), 2023 – 2028
Figure-05: United States – Type 2 Diabetes Population (Thousand), 2017 – 2022
Figure-06: United States – Forecast for Type 2 Diabetes Population (Thousand), 2023 – 2028
Figure-07: United States – Glucose Sensor Market Market (Million US$), 2017 – 2023
Figure-08: United States – Forecast for Glucose Sensor Market Market (Million US$), 2023 – 2028
Figure-09: United States – CGM Transmitter Market Market (Million US$), 2017 – 2023
Figure-10: United States – Forecast for CGM Transmitter Market Market (Million US$), 2023 – 2028
Figure-11: United States – CGM User (Thousand), 2017 – 2023
Figure-12: United States – Forecast for CGM User (Thousand),2023 – 2028
Figure-13: United States – Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-14: United States – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-15: United States – Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-16: United States – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-17: United States – Test Strips Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-18: United States – Forecast for Test Strips Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-19: United States – Test Strips Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-20: United States – Forecast for Test Strips Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-21: United States – Lancet Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-22: United States – Forecast for Lancet Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-23: United States – Lancet Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-24: United States – Forecast for Lancet Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-25: United States – Meter Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-26: United States – Forecast for Meter Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-27: United States – Meter Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-28: United States – Forecast for Meter Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-29: United States – Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2017 – 2022
Figure-30: United States – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2023 – 2028
Figure-31: United States – Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2017 – 2022
Figure-32: United States – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2023 – 2028
Figure-33: United States – Disposable Insulin Pen Market (Million US$), 2017 – 2023
Figure-34: United States – Forecast for Disposable Insulin Pen Market (Million US$), 2023 – 2028
Figure-35: United States – Reusable Insulin Pen Market (Million US$), 2017 – 2023
Figure-36: United States – Forecast for Reusable Insulin Pen Market (Million US$), 2023 – 2028
Figure-37: United States – Smart Insulin Pen Market (Million US$), 2017 – 2023
Figure-38: United States – Forecast for Smart Insulin Pen Market (Million US$), 2023 – 2028
Figure-39: United States – Disposable Insulin Pen User (Thousand), 2017 – 2022
Figure-40: United States – Forecast for Disposable Insulin Pen User (Thousand), 2023 – 2028
Figure-41: United States – Reusable Insulin Pen User (Thousand), 2017 – 2022
Figure-42: United States – Forecast for Reusable Insulin Pen User (Thousand), 2023 – 2028
Figure-43: United States – Smart Insulin Pen User (Thousand), 2017 – 2022
Figure-44: United States – Forecast for Smart Insulin Pen User (Thousand), 2023 – 2028
Figure-45: United States – Insulin Pen Needle Market Market (Million US$), 2017 – 2023
Figure-46: United States – Forecast for Pen Needle Market for Market (Million US$), 2023 – 2028
Figure-47: United States – Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-48: United States – Forecast for Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-49: United States – Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-50: United States – Forecast for Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-51: United States – Insulin Pump Type 1 Users (Thousand), 2017 – 2022
Figure-52: United States – Forecast for Insulin Pump Type 1 Users (Thousand), 2023 – 2028
Figure-53: United States – Insulin Pump Type 2 Users (Thousand), 2017 – 2022
Figure-54: United States – Forecast for Insulin Pump Type 2 Users (Thousand), 2023 – 2028
Figure-55: B. Braun Melsungen AG – Global Revenue (Billion US$), 2017 – 2022
Figure-56: B. Braun Melsungen AG – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-57: Eli Lilly – Global Revenue (Billion US$), 2017 – 2022
Figure-58: Eli Lilly – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-59: Terumo Corporation – Global Revenue (Billion US$), 2017 – 2022
Figure-60: Terumo Corporation – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-61: BD – Global Revenue (Billion US$), 2017 – 2022
Figure-62: BD – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-63: Novo Nordisk A/S – Global Revenue (Billion US$), 2017 – 2022
Figure-64: Novo Nordisk A/S – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-65: Ypsomed AG – Global Revenue (Billion US$), 2017 – 2022
Figure-66: Ypsomed AG – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-67: Medtronic – Global Revenue (Billion US$), 2017 – 2022
Figure-68: Medtronic – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-69: Insulet Corporation – Global Revenue (Billion US$), 2017 – 2022
Figure-70: Insulet Corporation – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-71: DarioHealth Corp – Global Revenue (Billion US$), 2017 – 2022
Figure-72: DarioHealth Corp – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-73: Abbott Laboratories – Global Revenue (Billion US$), 2017 – 2022
Figure-74: Abbott Laboratories – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-75: Dexcom Inc – Global Revenue (Billion US$), 2017 – 2022
Figure-76: Dexcom Inc – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-77: Roche – Global Revenue (Billion US$), 2017 – 2022
Figure-78: Roche – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-79: Tandem Diabetes Care – Global Revenue (Billion US$), 2017 – 2022
Figure-80: Tandem Diabetes Care – Forecast for Global Revenue (Billion US$), 2023 – 2028

List of Tables

Table-01: United States – Diabetes Market Share by Type (Percent), 2017 – 2022
Table-02: United States – Forecast for Diabetes Market Share by Type (Percent), 2023 – 2028